• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/20/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Initial reporter facility name: (b)(6) hospital.Initial reporter state: (b)(6).
 
Event or Problem Description
It was reported that the balloon ruptured.A ranger global dcb otw 6.0 x 60mm, 135cm was selected for use in the proximal superficial femoral artery (sfa).During the procedure, the balloon was advanced to the target lesion, which was 50% stenosed and had moderate calcification and tortuosity.The balloon was inflated once to 12 atm before it ruptured.The device was removed from the patient and the procedure was completed with another of the same device.No patient complications were reported, and the patient was in stable condition following the procedure.
 
Additional Manufacturer Narrative
E1: initial reporter facility name: (b)(6).E1 - initial reporter state: (b)(6).Device/media analysis: returned product consisted of a ranger drug coated balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed no damages.Microscopic examination revealed a longitudinal tear 44mm from the tip that was approximately 27mm long.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed there was a longitudinal tear in the balloon.
 
Event or Problem Description
It was reported that the balloon ruptured.A ranger global dcb otw 6.0 x 60mm, 135cm was selected for use in the proximal superficial femoral artery (sfa).During the procedure, the balloon was advanced to the target lesion, which was 50% stenosed and had moderate calcification and tortuosity.The balloon was inflated once to 12 atm before it ruptured.The device was removed from the patient and the procedure was completed with another of the same device.No patient complications were reported, and the patient was in stable condition following the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15756260
Report Number2124215-2022-45470
Device Sequence Number5127035
Product Code ONU
UDI-Device Identifier08714729976103
UDI-Public08714729976103
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/07/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number02099H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/20/2022
Supplement Date Received by Manufacturer11/30/2022
Initial Report FDA Received Date11/08/2022
Supplement Report FDA Received Date12/20/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/08/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-